GREGORY NFULLERGREGORY N FULLER8573FULLER, GREGORY NProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25086667Davoudi S, Anderlini P, Fuller GN, Kontoyiannis DPMycopathologiaA long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case. Mycopathologia. 2014 Dec; 178(5-6):465-70.Mycopathologia2014-08-03T00:00:002014A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.25391061Vann VR, Giuliari GP, Banda RM, Ch?vez-Barrios P, Fuller GN, Gombos DSRetinal cases & brief reportsChoroidal melanoma masquerading as panuveitis in a patient with multiple myeloma. Retin Cases Brief Rep. 2009; 3(2):152-5.Retin Cases Brief Rep2009-01-01T00:00:002009Choroidal melanoma masquerading as panuveitis in a patient with multiple myeloma.16613346Huo L, Moran CA, Fuller GN, Gladish G, Suster SAmerican journal of clinical pathologyPulmonary artery sarcoma: a clinicopathologic and immunohistochemical study of 12 cases. Am J Clin Pathol. 2006 Mar; 125(3):419-24.Am J Clin Pathol2006-03-01T00:00:002006Pulmonary artery sarcoma: a clinicopathologic and immunohistochemical study of 12 cases.24747968Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang WOncogeneTwo mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628.Oncogene2014-04-21T00:00:002014Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.25040885Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KDBrain pathology (Zurich, Switzerland)Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol. 2015 May; 25(3):266-75.Brain Pathol2014-10-29T00:00:002014Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.25302990Gressot LV, Doucette TA, Yang Y, Fuller GN, Heimberger AB, B?gler O, Rao A, Latha K, Rao GInternational journal of cancerSignal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis. Int J Cancer. 2015 May 01; 136(9):2047-54.Int J Cancer2014-10-23T00:00:002014Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.25465288Kong LY, Wei J, Haider AS, Liebelt BD, Ling X, Conrad CA, Fuller GN, Levine NB, Priebe W, Sawaya R, Heimberger ABJournal of neuroimmunologyTherapeutic targets in subependymoma. J Neuroimmunol. 2014 Dec 15; 277(1-2):168-75.J Neuroimmunol2014-10-31T00:00:002014Therapeutic targets in subependymoma.1515 Holcombe BlvdHouston77030-4009TXAuthorship 1639542Authorship 1642582Authorship 1644201Authorship 1709124Authorship 1710361Authorship 1713743Authorship 1714813Authorship 1716669Authorship 17194610Authorship 1721995Authorship 1722838Authorship 1724466Authorship 1724575Authorship 1729842Authorship 1730902Authorship 1731423Authorship 1735766Authorship 1738986Authorship 1739186Authorship 1740791Authorship 1742996Authorship 1743454Authorship 17443210Authorship 1744433Authorship 1744876Authorship 1748471Authorship 1749295Authorship 1750137Authorship 1753986Authorship 17596812Authorship 1761673Authorship 1765382Authorship 1765534Authorship 17665813Authorship 1771344Authorship 1773549Authorship 1776094Authorship 1779185Authorship 1779283Authorship 17793910Authorship 17802711Authorship 1782083Authorship 1786764Authorship 1793721Authorship 1794304Authorship 1795846Authorship 1798103Authorship 1800237Authorship 1805697Authorship 1808528Authorship 1812334Authorship 1821089Authorship 1821197Authorship 1833569Authorship 18338713Authorship 18343911Authorship 1836263Authorship 18368313Authorship 1843335Authorship 1845483Authorship 1845586Authorship 1849704Authorship 1852979Authorship 1856646Authorship 1858193Authorship 1865724Authorship 18685617Authorship 1868946Authorship 1869484Authorship 1872086Authorship 1886276Authorship 18883712Authorship 1890599Authorship 1893695Authorship 1895823Authorship 1898476Authorship 1901164Authorship 1902718Authorship 1910285Authorship 1910908Authorship 19134311Authorship 19185011Authorship 1919206Authorship 19233311Authorship 1932075Authorship 19321517Authorship 19516317Authorship 19593215Authorship 19608056149444Wiggins RC, Fuller G, Enna SJLife sciencesUndernutrition and the development of brain neurotransmitter systems. Life Sci. 1984 Nov 19; 35(21):2085-94.Life Sci1984-11-19T00:00:001984Undernutrition and the development of brain neurotransmitter systems.6478208Wiggins RC, Fuller GN, Brizzee L, Bissel AC, Samorajski TBrain researchMyelination of the rat optic nerve during postnatal undernourishment and recovery: a morphometric analysis. Brain Res. 1984 Aug 13; 308(2):263-72.Brain Res1984-08-13T00:00:001984Myelination of the rat optic nerve during postnatal undernourishment and recovery: a morphometric analysis.7139294Fuller GN, Divakaran P, Wiggins RCBrain researchThe effect of postnatal caffeine administration on brain myelination. Brain Res. 1982 Oct 07; 249(1):189-91.Brain Res1982-10-07T00:00:001982The effect of postnatal caffeine administration on brain myelination.11771519Fuller GN, Hess KR, Rhee CH, Yung WK, Sawaya RA, Bruner JM, Zhang WBrain pathology (Zurich, Switzerland)Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol. 2002 Jan; 12(1):108-16.Brain Pathol2002-01-01T00:00:002002Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets.12907597Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang WCancer researchInsulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003 Aug 01; 63(15):4315-21.Cancer Res2003-08-01T00:00:002003Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.15022276Hao X, Sun B, Hu L, L?hdesm?ki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang WCancerDifferential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004 Mar 15; 100(6):1110-22.Cancer2004-03-15T00:00:002004Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.15778693Kim JH, Tuziak T, Hu L, Wang Z, Bondaruk J, Kim M, Fuller G, Dinney C, Grossman HB, Baggerly K, Zhang W, Czerniak BLaboratory investigation; a journal of technical methods and pathologyAlterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Lab Invest. 2005 Apr; 85(4):532-49.Lab Invest2005-04-01T00:00:002005Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways.15824741Chen LL, Sabripour M, Wu EF, Prieto VG, Fuller GN, Frazier MLOncogeneA mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene. 2005 Jun 16; 24(26):4271-80.Oncogene2005-06-16T00:00:002005A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors.16088966McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape KCancerThe prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer. 2005 Oct 01; 104(7):1468-77.Cancer2005-10-01T00:00:002005The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.16931686Xu JJ, Walla BC, Diaz MF, Fuller GN, Gutstein HBAnesthesia and analgesiaIntermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance. Anesth Analg. 2006 Sep; 103(3):714-20.Anesth Analg2006-09-01T00:00:002006Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance.17606927Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, Zhang WProceedings of the National Academy of Sciences of the United States of AmericaInsulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci U S A. 2007 Jul 10; 104(28):11736-41.Proc Natl Acad Sci U S A2007-07-02T00:00:002007Insulin-like growth factor binding protein 2 promotes glioma development and progression.18517270Fuller GNArchives of pathology & laboratory medicineThe WHO Classification of Tumours of the Central Nervous System, 4th edition. Arch Pathol Lab Med. 2008 Jun; 132(6):906.Arch Pathol Lab Med2008-06-01T00:00:002008The WHO Classification of Tumours of the Central Nervous System, 4th edition.18565897Raslan O, Ketonen LM, Fuller GN, Schellingerhout DJournal of clinical oncology : official journal of the American Society of Clinical OncologyIntracranial Rosai-Dorfman disease with relapsing spinal lesions. J Clin Oncol. 2008 Jun 20; 26(18):3087-9.J Clin Oncol2008-06-20T00:00:002008Intracranial Rosai-Dorfman disease with relapsing spinal lesions.19148581Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan VJournal of neuro-oncologyReactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL. J Neurooncol. 2009 Jul; 93(3):303-18.J Neurooncol2009-01-16T00:00:002009Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.20008322Wu Y, Song SW, Sun J, Bruner JM, Fuller GN, Zhang WThe Journal of biological chemistryIIp45 inhibits cell migration through inhibition of HDAC6. J Biol Chem. 2010 Feb 05; 285(6):3554-3560.J Biol Chem2009-12-12T00:00:002009IIp45 inhibits cell migration through inhibition of HDAC6.22345562Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M, Hess K, Fuller GN, Zhang WProceedings of the National Academy of Sciences of the United States of AmericaInsulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-?B network. Proc Natl Acad Sci U S A. 2012 Feb 28; 109(9):3475-80.Proc Natl Acad Sci U S A2012-02-15T00:00:002012Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-?B network.Neuro-OncologyPalliative Care & Rehabilitation MedicineMD AndersonRAYMOND ESAWAYARAYMOND E SAWAYA8456SAWAYA, RAYMOND EProfessor6.062630.0020872936research areas4.959350.0137699243coauthor of188.83931.862559similar to11323selected publicationsAMY BHEIMBERGERAMY B HEIMBERGER9035HEIMBERGER, AMY BProfessorJOHN FREDERICKDE GROOTJOHN FREDERICK DE GROOT9019DE GROOT, JOHN FREDERICKProfessorAuthorship 2134571Authorship 2139802Authorship 2145162Authorship 2184572Authorship 2187154Authorship 2195164Authorship 2195194Authorship 2204637Authorship 2222476Authorship 2223307Authorship 2227383Authorship 2229522Authorship 2233791Authorship 2245535Authorship 2255885Authorship 2258986Authorship 2259694Authorship 2259974Authorship 2266742Authorship 22829910Authorship 2287403Authorship 2296035Authorship 2298553Authorship 23399212Authorship 2349034Authorship 23553211443038Lueder GTAmerican journal of ophthalmologySuccessful therapy for trilateral retinoblastoma. Am J Ophthalmol. 1992 Nov 15; 114(5):646-7.Am J Ophthalmol1992-11-15T00:00:001992Successful therapy for trilateral retinoblastoma.6419986Fuller GN, Johnston DA, Wiggins RCBrain researchThe relationship between nutritional adequacy and brain myelin accumulation: a comparison of varying degrees of well fed and undernourished rats. Brain Res. 1984 Jan 02; 290(1):195-8.Brain Res1984-01-02T00:00:001984The relationship between nutritional adequacy and brain myelin accumulation: a comparison of varying degrees of well fed and undernourished rats.7117468Wiggins RC, Fuller GN, Dafny NExperimental neurologyPropagation of photic evoked responses recorded from the retina, optic chiasm, lateral geniculate body, and visual cortex of the nutritionally rehabilitated rat visual system. Exp Neurol. 1982 Sep; 77(3):644-53.Exp Neurol1982-09-01T00:00:001982Propagation of photic evoked responses recorded from the retina, optic chiasm, lateral geniculate body, and visual cortex of the nutritionally rehabilitated rat visual system.7392794Wiggins RC, Fuller GN, Dafny NLife sciencesThe electroretinogram of adult rats following a period of postnatal undernutrition and prolonged nutritional rehabilitation. Life Sci. 1980 Apr 07; 26(14):1169-74.Life Sci1980-04-07T00:00:001980The electroretinogram of adult rats following a period of postnatal undernutrition and prolonged nutritional rehabilitation.11770894Begemann M, Fuller GN, Holland ECBrain pathology (Zurich, Switzerland)Genetic modeling of glioma formation in mice. Brain Pathol. 2002 Jan; 12(1):117-32.Brain Pathol2002-01-01T00:00:002002Genetic modeling of glioma formation in mice.11770905Wang H, Wang H, Zhang W, Fuller GNBrain pathology (Zurich, Switzerland)Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol. 2002 Jan; 12(1):95-107.Brain Pathol2002-01-01T00:00:002002Tissue microarrays: applications in neuropathology research, diagnosis, and education.12479704Kim S, Dougherty ER, Shmulevich I, Hess KR, Hamilton SR, Trent JM, Fuller GN, Zhang WMolecular cancer therapeuticsIdentification of combination gene sets for glioma classification. Mol Cancer Ther. 2002 Nov; 1(13):1229-36.Mol Cancer Ther2002-11-01T00:00:002002Identification of combination gene sets for glioma classification.12484570Fuller CE, Wang H, Zhang W, Fuller GN, Perry AJournal of neuropathology and experimental neurologyHigh-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol. 2002 Dec; 61(12):1078-84.J Neuropathol Exp Neurol2002-12-01T00:00:002002High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).12488763Shukla V, Hayman LA, Ly C, Fuller G, Taber KHJournal of computer assisted tomographyAdult cranial dura I: intrinsic vessels. J Comput Assist Tomogr. 2002 Nov-Dec; 26(6):1069-74.J Comput Assist Tomogr2002-11-01T00:00:002002Adult cranial dura I: intrinsic vessels.15184909Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GNLaboratory investigation; a journal of technical methods and pathologyAnalysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest. 2004 Aug; 84(8):941-51.Lab Invest2004-08-01T00:00:002004Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.15753393de Groot JF, Liu TJ, Fuller G, Yung WKCancer researchThe excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 2005 Mar 01; 65(5):1934-40.Cancer Res2005-03-01T00:00:002005The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.15867349Song SW, Fuller GN, Zheng H, Zhang WCancer researchInactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas. Cancer Res. 2005 May 01; 65(9):3562-7.Cancer Res2005-05-01T00:00:002005Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas.15967117Dai C, Lyustikman Y, Shih A, Hu X, Fuller GN, Rosenblum M, Holland ECNeoplasia (New York, N.Y.)The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats. Neoplasia. 2005 Apr; 7(4):397-406.Neoplasia2005-04-01T00:00:002005The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.16699322Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape KThe American journal of surgical pathologyAssessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol. 2006 May; 30(5):657-64.Am J Surg Pathol2006-05-01T00:00:002006Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.17076519Fuller GNArchives of pathology & laboratory medicineNarrowing the differential diagnosis in surgical neuropathology. Arch Pathol Lab Med. 2006 Nov; 130(11):1602.Arch Pathol Lab Med2006-11-01T00:00:002006Narrowing the differential diagnosis in surgical neuropathology.18246408Li JY, Wang H, May S, Song X, Fueyo J, Fuller GN, Wang HJournal of neuro-oncologyConstitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas. J Neurooncol. 2008 May; 88(1):11-7.J Neurooncol2008-02-02T00:00:002008Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas.18317690de Groot JF, Piao Y, Lu L, Fuller GN, Yung WKJournal of neuro-oncologyKnockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol. 2008 Jun; 88(2):121-33.J Neurooncol2008-06-01T00:00:002008Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation.18373644Wang H, Arun BK, Wang H, Fuller GN, Zhang W, Middleton LP, Sahin AAThe breast journalIGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas. Breast J. 2008 May-Jun; 14(3):261-7.Breast J2008-03-27T00:00:002008IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.18532929Scheithauer BW, Fuller GN, VandenBerg SRBrain pathology (Zurich, Switzerland)The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol. 2008 Jul; 18(3):307-16.Brain Pathol2008-07-01T00:00:002008The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology.19252432Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, Tucker SL, Buchholz TAThe American journal of surgical pathologyEven low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol. 2009 May; 33(5):759-67.Am J Surg Pathol2009-05-01T00:00:002009Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.19967449Higgins RJ, Dickinson PJ, LeCouteur RA, Bollen AW, Wang H, Wang H, Corely LJ, Moore LM, Zang W, Fuller GNJournal of neuro-oncologySpontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol. 2010 May; 98(1):49-55.J Neurooncol2009-12-05T00:00:002009Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.20514406Mendes KN, Wang GK, Fuller GN, Zhang WInternational journal of oncologyJNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration. Int J Oncol. 2010 Jul; 37(1):143-53.Int J Oncol2010-07-01T00:00:002010JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration.20799335Gopalakrishnan V, Bie B, Sinnappah-Kang ND, Adams H, Fuller GN, Pan ZZ, Majumder SStem cells (Dayton, Ohio)Myoblast-derived neuronal cells form glutamatergic neurons in the mouse cerebellum. Stem Cells. 2010 Oct; 28(10):1839-47.Stem Cells2010-10-01T00:00:002010Myoblast-derived neuronal cells form glutamatergic neurons in the mouse cerebellum.21352693Moore LM, Holmes KM, Fuller GN, Zhang WChinese journal of cancerOncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model. Chin J Cancer. 2011 Mar; 30(3):163-72.Chin J Cancer2011-03-01T00:00:002011Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model.24147027Pong WW, Walker J, Wylie T, Magrini V, Luo J, Emnett RJ, Choi J, Cooper ML, Griffith M, Griffith OL, Rubin JB, Fuller GN, Piwnica-Worms D, Feng X, Hambardzumyan D, DiPersio JF, Mardis ER, Gutmann DHPloS oneF11R is a novel monocyte prognostic biomarker for malignant glioma. PLoS One. 2013; 8(10):e77571.PLoS One2013-10-11T00:00:002013F11R is a novel monocyte prognostic biomarker for malignant glioma.24240114Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, de Groot JFClinical cancer research : an official journal of the American Association for Cancer ResearchNeutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res. 2014 Jan 01; 20(1):187-98.Clin Cancer Res2013-11-15T00:00:002013Neutrophils promote the malignant glioma phenotype through S100A4.Authorship 2366202Authorship 2366692Authorship 2381762Authorship 2384431Authorship 2384582Authorship 2421513Authorship 2445093Authorship 2447682Authorship 2453966Authorship 2467642Authorship 2471904Authorship 2477472Authorship 2479317Authorship 2485944Authorship 2491312Authorship 2497547Authorship 2503751Authorship 2511503Authorship 2519972Authorship 2522757Authorship 2528572Authorship 2541032Authorship 2551983Authorship 2552553Authorship 2561878Authorship 2579089Authorship 2582933Authorship 2588614Authorship 2615867438825Wiggins RC, Fuller GN, Bell MEJournal of neurochemistryIncorporation of leucine metabolites into brain and sciatic nerve myelin. J Neurochem. 1979 May; 32(5):1579-82.J Neurochem1979-05-01T00:00:001979Incorporation of leucine metabolites into brain and sciatic nerve myelin.458464Wiggins RC, Fuller GN, Astrello JM, Rigor BMJournal of neurochemistryDecreased myelin synthesis in developing rats following repeated pre- and perinatal exposure to subanesthetic amounts of halothane. J Neurochem. 1979 Jul; 33(1):361-3.J Neurochem1979-07-01T00:00:001979Decreased myelin synthesis in developing rats following repeated pre- and perinatal exposure to subanesthetic amounts of halothane.4080102Fuller GN, Rigor BM, Wiggins RC, Dafny NNeuropharmacologyProlonged daily inhalation of halothane modifies the dose-response pattern to acute administration of halothane. An electrophysiological study. Neuropharmacology. 1985 Nov; 24(11):1033-8.Neuropharmacology1985-11-01T00:00:001985Prolonged daily inhalation of halothane modifies the dose-response pattern to acute administration of halothane. An electrophysiological study.7238746Gottesfeld Z, Fuller GN, Wiggins RCExperientiaAdrenergic neuroplasticity is maintained in the nutritional rehabilitated adult rat. Experientia. 1981 Feb 15; 37(2):168-9.Experientia1981-02-15T00:00:001981Adrenergic neuroplasticity is maintained in the nutritional rehabilitated adult rat.7279118Wiggins RC, Fuller GNNeurochemical researchAnalysis of distribution of rat sciatic nerve protein among soluble, insoluble, and myelin subfraction. Neurochem Res. 1981 Jun; 6(6):719-27.Neurochem Res1981-06-01T00:00:001981Analysis of distribution of rat sciatic nerve protein among soluble, insoluble, and myelin subfraction.10993507Verma KK, Forman AD, Fuller GN, Dimachkie MM, Vriesendorp FJJournal of neurologyCauda equina syndrome as the isolated presentation of sarcoidosis. J Neurol. 2000 Jul; 247(7):573-4.J Neurol2000-07-01T00:00:002000Cauda equina syndrome as the isolated presentation of sarcoidosis.12084350Tremont-Lukats IW, Fuller GN, Ribalta T, Giglio P, Groves MDNeuro-oncologyParaneoplastic chorea: case study with autopsy confirmation. Neuro Oncol. 2002 07; 4(3):192-5.Neuro Oncol2002-07-01T00:00:002002Paraneoplastic chorea: case study with autopsy confirmation.12829152Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MHInternational journal of radiation oncology, biology, physicsGliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Jul 15; 56(4):1137-46.Int J Radiat Oncol Biol Phys2003-07-15T00:00:002003Gliomatosis cerebri: improved outcome with radiotherapy.12944701Baumgartner JE, Ater JL, Ha CS, Kuttesch JF, Leeds NE, Fuller GN, Wilson RJPediatric neurosurgeryPathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors. Pediatr Neurosurg. 2003 Oct; 39(4):201-7.Pediatr Neurosurg2003-10-01T00:00:002003Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors.15018124Vogel H, Fuller GNAnnals of diagnostic pathologyPrimitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems. Ann Diagn Pathol. 2003 Dec; 7(6):387-98.Ann Diagn Pathol2003-12-01T00:00:002003Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems.15342366Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier MLCancer researchA missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004 Sep 01; 64(17):5913-9.Cancer Res2004-09-01T00:00:002004A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.15913428Spencer ML, Neto AG, Fuller GN, Luna MAArchives of pathology & laboratory medicineIntracranial extension of acinic cell carcinoma of the parotid gland. Arch Pathol Lab Med. 2005 Jun; 129(6):780-2.Arch Pathol Lab Med2005-06-01T00:00:002005Intracranial extension of acinic cell carcinoma of the parotid gland.16602477Costelloe CM, Fuller GN, Kumar AJ, Cline K, Neitzschman HRThe Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical SocietyRadiology case of the month. Palmar mass and finger weakness. Fibrolipomatous hamartoma. J La State Med Soc. 2006 Jan-Feb; 158(1):7-8.J La State Med Soc2006-01-01T00:00:002006Radiology case of the month. Palmar mass and finger weakness. Fibrolipomatous hamartoma.16636750Levin VA, Phuphanich S, Yung WK, Forsyth PA, Maestro RD, Perry JR, Fuller GN, Baillet MJournal of neuro-oncologyRandomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. J Neurooncol. 2006 Jul; 78(3):295-302.J Neurooncol2006-04-25T00:00:002006Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.16700616Wang H, Wang H, Zhang W, Fuller GNTechnology in cancer research & treatmentOverexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat. 2006 Jun; 5(3):195-9.Technol Cancer Res Treat2006-06-01T00:00:002006Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study.17483310Olson MV, Johnson DG, Jiang H, Xu J, Alonso MM, Aldape KD, Fuller GN, Bekele BN, Yung WK, Gomez-Manzano C, Fueyo JCancer researchTransgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9.Cancer Res2007-05-01T00:00:002007Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors.17598822Fuller GN, Scheithauer BWBrain pathology (Zurich, Switzerland)The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 2007 Jul; 17(3):304-7.Brain Pathol2007-07-01T00:00:002007The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.17598825Brat DJ, Scheithauer BW, Fuller GN, Tihan TBrain pathology (Zurich, Switzerland)Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol. 2007 Jul; 17(3):319-24.Brain Pathol2007-07-01T00:00:002007Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma.19124484Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA, Frost JACancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyCoexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):80-6.Cancer Epidemiol Biomarkers Prev2009-01-01T00:00:002009Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis.19358341Zhang W, Fuller GCancer biology & therapyIGFBP2 as a brain tumor oncogene. Cancer Biol Ther. 2007 Jul; 6(7):995-6.Cancer Biol Ther2007-07-01T00:00:002007IGFBP2 as a brain tumor oncogene.20098296Rao P, Fuller GN, Prieto VGThe American Journal of dermatopathologyExpression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall. Am J Dermatopathol. 2010 May; 32(3):262-266.Am J Dermatopathol2010-05-01T00:00:002010Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall.20167811de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, Conrad CANeuro-oncologyTumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol. 2010 Mar; 12(3):233-42.Neuro Oncol2010-01-06T00:00:002010Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.20464403Perry A, Burton SS, Fuller GN, Robinson CA, Palmer CA, Resch L, Bigio EH, Gujrati M, Rosenblum MKActa neuropathologicaOligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall. Acta Neuropathol. 2010 Aug; 120(2):237-52.Acta Neuropathol2010-05-13T00:00:002010Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.21257861Raslan OA, Schellingerhout D, Fuller GN, Ketonen LMAJR. American journal of roentgenologyRosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol. 2011 Feb; 196(2):W187-93.AJR Am J Roentgenol2011-02-01T00:00:002011Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients.21464220Agnihotri S, Wolf A, Munoz DM, Smith CJ, Gajadhar A, Restrepo A, Clarke ID, Fuller GN, Kesari S, Dirks PB, McGlade CJ, Stanford WL, Aldape K, Mischel PS, Hawkins C, Guha AThe Journal of experimental medicineA GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med. 2011 Apr 11; 208(4):689-702.J Exp Med2011-04-04T00:00:002011A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas.22772980Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KDActa neuropathologicaLow rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathol. 2012 Sep; 124(3):449-51.Acta Neuropathol2012-07-08T00:00:002012Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.22989791Gadgil N, Kupferman M, Smitherman S, Fuller GN, Rao GJournal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaCurvularia brain abscess. J Clin Neurosci. 2013 Jan; 20(1):173-5.J Clin Neurosci2012-09-16T00:00:002012Curvularia brain abscess.23109653Theeler BJ, Yung WK, Fuller GN, De Groot JFNeurologyMoving toward molecular classification of diffuse gliomas in adults. Neurology. 2012 Oct 30; 79(18):1917-26.Neurology2012-10-30T00:00:002012Moving toward molecular classification of diffuse gliomas in adults.24809734Gabrusiewicz K, Liu D, Cortes-Santiago N, Hossain MB, Conrad CA, Aldape KD, Fuller GN, Marini FC, Alonso MM, Idoate MA, Gilbert MR, Fueyo J, Gomez-Manzano COncotargetAnti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget. 2014 Apr 30; 5(8):2208-20.Oncotarget2014-04-30T00:00:002014Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes.Authorship 2627631Authorship 2634241Authorship 2648282Authorship 2652898Authorship 2669136Authorship 2674963Authorship 27039671443039Abramson DHAmerican journal of ophthalmologySuccessful therapy for trilateral retinoblastoma. Am J Ophthalmol. 1992 Nov 15; 114(5):647-8.Am J Ophthalmol1992-11-15T00:00:001992Successful therapy for trilateral retinoblastoma.6478252Fuller GN, Wiggins RCBrain researchDifferential growth recovery within the brains of postnatally undernourished rats. Brain Res. 1984 Aug; 317(2):280-2.Brain Res1984-08-01T00:00:001984Differential growth recovery within the brains of postnatally undernourished rats.11791179Adachi Y, Chandrasekar N, Kin Y, Lakka SS, Mohanam S, Yanamandra N, Mohan PM, Fuller GN, Fang B, Fueyo J, Dinh DH, Olivero WC, Tamiya T, Ohmoto T, Kyritsis AP, Rao JSOncogeneSuppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene. 2002 Jan 03; 21(1):87-95.Oncogene2002-01-03T00:00:002002Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.12490478Tran TA, Fuller GN, Whitman GJ, Schomer DFAJR. American journal of roentgenologyRadiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Delayed cerebral radiation necrosis. AJR Am J Roentgenol. 2003 Jan; 180(1):70.AJR Am J Roentgenol2003-01-01T00:00:002003Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Delayed cerebral radiation necrosis.16478988Su X, Gopalakrishnan V, Stearns D, Aldape K, Lang FF, Fuller G, Snyder E, Eberhart CG, Majumder SMolecular and cellular biologyAbnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol Cell Biol. 2006 Mar; 26(5):1666-78.Mol Cell Biol2006-03-01T00:00:002006Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.16569642Wang GK, Hu L, Fuller GN, Zhang WThe Journal of biological chemistryAn interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem. 2006 May 19; 281(20):14085-91.J Biol Chem2006-03-28T00:00:002006An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility.21439246Cogdell D, Chung W, Liu Y, McDonald JM, Aldape K, Issa JP, Fuller GN, Zhang WChinese journal of cancerTumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma. Chin J Cancer. 2011 Apr; 30(4):247-53.Chin J Cancer2011-04-01T00:00:002011Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma.Authorship 2747702Authorship 2752437Authorship 2755313Authorship 2776733Authorship 277703411770904Zhang W, Wang H, Song SW, Fuller GNBrain pathology (Zurich, Switzerland)Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm. Brain Pathol. 2002 Jan; 12(1):87-94.Brain Pathol2002-01-01T00:00:002002Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm.18486896Williams MD, Asa SL, Fuller GNAnnals of diagnostic pathologyMedullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol. 2008 Jun; 12(3):199-203.Ann Diagn Pathol2007-08-17T00:00:002007Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis.19018150Kuo SH, Debnam JM, Fuller GN, de Groot JOncologyWernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients. Oncology. 2009; 76(1):10-8.Oncology2008-11-19T00:00:002008Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients.24102930George AA, Fuller GN, Langford LA, Simon CD, Zingalis AA, Mathis DAHistopathologyUnusual presentation of a granular cell astrocytoma. Histopathology. 2013 Dec; 63(6):883-5.Histopathology2013-09-16T00:00:002013Unusual presentation of a granular cell astrocytoma.24305706Yust-Katz S, Anderson MD, Liu D, Wu J, Yuan Y, Olar A, Fuller GN, Brown PD, de-Groot JFNeuro-oncologyClinical and prognostic features of adult patients with gangliogliomas. Neuro Oncol. 2014 Mar; 16(3):409-13.Neuro Oncol2013-12-04T00:00:002013Clinical and prognostic features of adult patients with gangliogliomas.Authorship 2786619Authorship 2789013Authorship 2789517Authorship 2789974Authorship 27901413Authorship 2794273Authorship 2796668Authorship 2798304Authorship 28014018226061751Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang JThe New England journal of medicineComprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98.N Engl J Med2015-06-10T00:00:002015Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.Authorship 2825083Authorship 29015912Authorship 2907546Authorship 2917944Authorship 29545513Authorship 2955555Authorship 2958952Authorship 2960373Authorship 2977259Authorship 2999257Authorship 3006036Authorship 30199724Authorship 3124515Authorship 315014312086591Hu L, Wang J, Baggerly K, Wang H, Fuller GN, Hamilton SR, Coombes KR, Zhang WBMC genomicsObtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics. 2002 Jun 21; 3:16.BMC Genomics2002-06-21T00:00:002002Obtaining reliable information from minute amounts of RNA using cDNA microarrays.17047730Lassman AB, Dai C, Fuller GN, Vickers AJ, Holland ECNeuron glia biologyOverexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biol. 2004 May; 1(2):157-63.Neuron Glia Biol2004-05-01T00:00:002004Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.18787681Liang JJ, Alrawi S, Fuller GN, Tan DInternational journal of clinical and experimental pathologyCarcinoid tumors arising in tailgut cysts may be associated with estrogen receptor status: case report and review of the literature. Int J Clin Exp Pathol. 2008 Jan 01; 1(6):539-43.Int J Clin Exp Pathol2008-01-01T00:00:002008Carcinoid tumors arising in tailgut cysts may be associated with estrogen receptor status: case report and review of the literature.24986181Cachia D, Prado MP, Theeler B, Hamilton J, McCutcheon I, Fuller GNClinical neuropathologySynchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11.Clin Neuropathol2014-11-01T00:00:002014Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report.24990071Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P, International Society Of Neuropathology--HaarlemBrain pathology (Zurich, Switzerland)International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014 Sep; 24(5):429-35.Brain Pathol2014-09-10T00:00:002014International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading.25251307Saade R, Hessel A, Ginsberg L, Fuller G, Bell DHead & neckPrimary extradural meningioma presenting as a neck mass: Case report and review of the literature. Head Neck. 2015 Aug; 37(8):E92-5.Head Neck2015-06-16T00:00:002015Primary extradural meningioma presenting as a neck mass: Case report and review of the literature.25737557Turner KM, Sun Y, Ji P, Granberg KJ, Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, Shmulevich I, Yung WK, Fuller GN, Zhang WProceedings of the National Academy of Sciences of the United States of AmericaGenomically amplified Akt3 activates DNA repair pathway and promotes glioma progression. Proc Natl Acad Sci U S A. 2015 Mar 17; 112(11):3421-6.Proc Natl Acad Sci U S A2015-03-03T00:00:002015Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.25749579Edson MA, Fuller GN, Allen PK, Levine NB, Ghia AJ, Mahajan A, Brown PD, DeMonte F, Li JWorld neurosurgeryOutcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. World Neurosurg. 2015 Jul; 84(1):76-81.World Neurosurg2015-03-05T00:00:002015Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region.25783823Phillips J, Tihan T, Fuller GSurgical pathology clinicsPractical molecular pathology and histopathology of embryonal tumors. Surg Pathol Clin. 2015 Mar; 8(1):73-88.Surg Pathol Clin2014-12-15T00:00:002014Practical molecular pathology and histopathology of embryonal tumors.25873508Lau SK, Cykowski MD, Desai S, Cao Y, Fuller GN, Bruner J, Okazaki IAmerican journal of clinical pathologyPrimary rhabdomyosarcoma of the pineal gland. Am J Clin Pathol. 2015 May; 143(5):728-33.Am J Clin Pathol2015-05-01T00:00:002015Primary rhabdomyosarcoma of the pineal gland.26323991Liu Q, Liu Y, Li W, Wang X, Sawaya R, Lang FF, Yung WK, Chen K, Fuller GN, Zhang WActa neuropathologicaGenetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathol. 2015 Oct; 130(4):587-97.Acta Neuropathol2015-09-01T00:00:002015Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.26354773Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JFJournal of neuro-oncologyPrimary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.J Neurooncol2015-09-09T00:00:002015Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.26558781Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, Suki D, Colman H, Bhat KP, Sulman EP, Aldape K, Colen RR, Verhaak RG, Lu Z, Fuller GN, Huang S, Lang FF, Sawaya R, Hegi M, Majumder SThe Journal of neuroscience : the official journal of the Society for NeuroscienceMir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112.J Neurosci2015-11-11T00:00:002015Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.26564007Liang L, Zhang Y, Malpica A, Ramalingam P, Euscher ED, Fuller GN, Liu JModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncGliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol. 2015 Dec; 28(12):1613-20.Mod Pathol2015-11-13T00:00:002015Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases.12734316Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FFJournal of the National Cancer InstitutePreclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60.J Natl Cancer Inst2003-05-07T00:00:002003Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.14523768Hong DS, Jacobson KL, Raad II, de Lima M, Anderlini P, Fuller GN, Ippoliti C, Cool RM, Leeds NE, Narvios A, Han XY, Padula A, Champlin RE, Hosing CClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaWest Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis. 2003 Oct 15; 37(8):1044-9.Clin Infect Dis2003-09-18T00:00:002003West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.14567605Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DPJournal of neurosurgeryFusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg. 2003 Oct; 99(4):693-700.J Neurosurg2003-10-01T00:00:002003Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis.14617774Song SW, Fuller GN, Khan A, Kong S, Shen W, Taylor E, Ramdas L, Lang FF, Zhang WProceedings of the National Academy of Sciences of the United States of AmericaIIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):13970-5.Proc Natl Acad Sci U S A2003-11-14T00:00:002003IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion.14743913Maldaun MV, Suki D, Lang FF, Prabhu S, Shi W, Fuller GN, Wildrick DM, Sawaya RJournal of neurosurgeryCystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg. 2004 Jan; 100(1):61-7.J Neurosurg2004-01-01T00:00:002004Cystic glioblastoma multiforme: survival outcomes in 22 cases.14744083Wang H, Shen SS, Wang H, Diwan AH, Zhang W, Fuller GN, Prieto VGJournal of cutaneous pathologyExpression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol. 2003 Nov; 30(10):599-605.J Cutan Pathol2003-11-01T00:00:002003Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions.12131432Marmor E, Fourney DR, Rhines LD, Skibber JM, Fuller GN, Gokaslan ZLJournal of spinal disorders & techniquesSacrococcygeal ganglioneuroma. J Spinal Disord Tech. 2002 Jun; 15(3):265-8.J Spinal Disord Tech2002-06-01T00:00:002002Sacrococcygeal ganglioneuroma.74Professor10Assistant Professor14Associate Professor6Adjunct Professor12182418Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya RNeurosurgeryNecrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery. 2002 Jul; 51(1):2-12; discussion 12-3.Neurosurgery2002-07-01T00:00:002002Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.ALIHAIDERALI HAIDER11891HAIDER, ALIAssistant Professor16077969Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang WOncology reportsMolecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression. Oncol Rep. 2005 Sep; 14(3):651-6.Oncol Rep2005-09-01T00:00:002005Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.16119901Cohen ZR, Marmor E, Fuller GN, DeMonte FNeurosurgical focusMisdiagnosis of olfactory neuroblastoma. Neurosurg Focus. 2002 May 15; 12(5):e3.Neurosurg Focus2002-05-15T00:00:002002Misdiagnosis of olfactory neuroblastoma.12839017Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WKJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003 Jul 01; 21(13):2508-18.J Clin Oncol2003-07-01T00:00:002003Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.16410724McDonald JM, Dunlap S, Cogdell D, Dunmire V, Wei Q, Starzinski-Powitz A, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang WCancer biology & therapyThe SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration. Cancer Biol Ther. 2006 Mar; 5(3):300-4.Cancer Biol Ther2006-03-09T00:00:002006The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration.12356357Lang FF, Gilbert MR, Puduvalli VK, Weinberg J, Levin VA, Yung WK, Sawaya R, Fuller GN, Conrad CANeuro-oncologyToward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies. Neuro Oncol. 2002 10; 4(4):268-77.Neuro Oncol2002-10-01T00:00:002002Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies.17189382Lee OH, Xu J, Fueyo J, Fuller GN, Aldape KD, Alonso MM, Piao Y, Liu TJ, Lang FF, Bekele BN, Gomez-Manzano CMolecular cancer research : MCRExpression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res. 2006 Dec; 4(12):915-26.Mol Cancer Res2006-12-01T00:00:002006Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix.14769134McCutcheon IE, Hentschel SJ, Fuller GN, Jin W, Cote GJNeuro-oncologyExpression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain. Neuro Oncol. 2004 Jan; 6(1):9-14.Neuro Oncol2004-01-01T00:00:002004Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain.12675313Brown HM, McCutcheon IE, Leeds NE, Schomer DS, Luna MA, Fuller GNJournal of neuro-oncologyMelanoma metastatic to central neurocytoma: a novel case of tumor-to-tumor metastasis. J Neurooncol. 2003 Feb; 61(3):209-14.J Neurooncol2003-02-01T00:00:002003Melanoma metastatic to central neurocytoma: a novel case of tumor-to-tumor metastasis.17575219Barnett JA, Urbauer DL, Murray GI, Fuller GN, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchCytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res. 2007 Jun 15; 13(12):3559-67.Clin Cancer Res2007-06-15T00:00:002007Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.27246830Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang SCancer researchmiR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis. Cancer Res. 2016 07 15; 76(14):4293-304.Cancer Res2016-05-31T00:00:002016miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.15214828Ribalta T, McCutcheon IE, Neto AG, Gupta D, Kumar AJ, Biddle DA, Langford LA, Bruner JM, Leeds NE, Fuller GNArchives of pathology & laboratory medicineTextiloma (gossypiboma) mimicking recurrent intracranial tumor. Arch Pathol Lab Med. 2004 Jul; 128(7):749-58.Arch Pathol Lab Med2004-07-01T00:00:002004Textiloma (gossypiboma) mimicking recurrent intracranial tumor.15377909Saadati H, Calvano C, Diba R, Fuller GN, Gombos D, De Monte F, Urso R, Esmaeli BOphthalmic plastic and reconstructive surgeryOrbital and optic chiasmal extension of uveal melanoma. Ophthalmic Plast Reconstr Surg. 2004 Sep; 20(5):387-90.Ophthalmic Plast Reconstr Surg2004-09-01T00:00:002004Orbital and optic chiasmal extension of uveal melanoma.14734472Raza SM, Fuller GN, Rhee CH, Huang S, Hess K, Zhang W, Sawaya RClinical cancer research : an official journal of the American Association for Cancer ResearchIdentification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):212-21.Clin Cancer Res2004-01-01T00:00:002004Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis.19805356Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, Sawaya R, Bruner JM, Fuller GN, Zhang WProceedings of the National Academy of Sciences of the United States of AmericaIGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proc Natl Acad Sci U S A. 2009 Sep 29; 106(39):16675-9.Proc Natl Acad Sci U S A2009-09-16T00:00:002009IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.20921210Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchIntratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses. Clin Cancer Res. 2010 Dec 01; 16(23):5722-33.Clin Cancer Res2010-10-04T00:00:002010Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.21183793Staquicini FI, Ozawa MG, Moya CA, Driessen WH, Barbu EM, Nishimori H, Soghomonyan S, Flores LG, Liang X, Paolillo V, Alauddin MM, Basilion JP, Furnari FB, Bogler O, Lang FF, Aldape KD, Fuller GN, H??k M, Gelovani JG, Sidman RL, Cavenee WK, Pasqualini R, Arap WThe Journal of clinical investigationSystemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011 Jan; 121(1):161-73.J Clin Invest2010-12-22T00:00:002010Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.15767543Fuller GN, Su X, Price RE, Cohen ZR, Lang FF, Sawaya R, Majumder SMolecular cancer therapeuticsMany human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Mol Cancer Ther. 2005 Mar; 4(3):343-9.Mol Cancer Ther2005-03-01T00:00:002005Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16.21792892Hatiboglu MA, Kong LY, Wei J, Wang Y, McEnery KA, Fuller GN, Qiao W, Davies MA, Priebe W, Heimberger ABInternational journal of cancerThe tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models. Int J Cancer. 2012 Jul 01; 131(1):8-17.Int J Cancer2011-08-24T00:00:002011The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.16729017Cheung HC, Corley LJ, Fuller GN, McCutcheon IE, Cote GJModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPolypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol. 2006 Aug; 19(8):1034-41.Mod Pathol2006-05-26T00:00:002006Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma.22445362Raghunathan A, Olar A, Vogel H, Parker JR, Coventry SC, Debski R, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Fuller GNAnnals of diagnostic pathologyIsocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol. 2012 Aug; 16(4):255-9.Ann Diagn Pathol2012-03-23T00:00:002012Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.23007860Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter MThe Journal of pathologyTranscriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol. 2013 Feb; 229(3):449-59.J Pathol2013-02-01T00:00:002013Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma.18000859Masoudi A, Amini E, Wolff JE, Fuller GN, Ketonen L, Mahajan APediatric blood & cancerShrinkage of germinoma by dexamethasone only. Pediatr Blood Cancer. 2008 May; 50(5):1079.Pediatr Blood Cancer2008-05-01T00:00:002008Shrinkage of germinoma by dexamethasone only.18698034Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Sun W, Qiao W, Hiraoka N, Fuller GNClinical cancer research : an official journal of the American Association for Cancer ResearchIncidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin Cancer Res. 2008 Aug 15; 14(16):5166-72.Clin Cancer Res2008-08-15T00:00:002008Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.19088040Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N, Priebe W, Sawaya R, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchThe incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res. 2008 Dec 15; 14(24):8228-35.Clin Cancer Res2008-12-15T00:00:002008The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.19663549Hassaneen W, Suki D, Salaskar AL, Wildrick DM, Lang FF, Fuller GN, Sawaya RJournal of neurosurgerySurgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience. J Neurosurg. 2010 May; 112(5):1046-55.J Neurosurg2010-05-01T00:00:002010Surgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience.19544396Rokes C, Ketonen LM, Fuller GN, Weinberg J, Slopis JM, Wolff JEPediatric blood & cancerImaging and spectroscopic findings in meningioangiomatosis. Pediatr Blood Cancer. 2009 Oct; 53(4):672-4.Pediatr Blood Cancer2009-10-01T00:00:002009Imaging and spectroscopic findings in meningioangiomatosis.19657240Rodney AJ, Gombos DS, Fuller GN, Pagliaro LC, Tannir NMAmerican journal of clinical oncologyChoroidal and conjunctival metastases from renal cell carcinoma. Am J Clin Oncol. 2009 Aug; 32(4):448-9.Am J Clin Oncol2009-08-01T00:00:002009Choroidal and conjunctival metastases from renal cell carcinoma.27231814Verla T, Thomas JG, Thomazy V, Fuller GN, Shaibani A, Omeis IJournal of neurosurgery. SpineFulminant spinal cord compression caused by postradiation inflammatory pseudotumor with rapid response to steroids: case report. J Neurosurg Spine. 2016 Nov; 25(5):660-664.J Neurosurg Spine2016-05-27T00:00:002016Fulminant spinal cord compression caused by postradiation inflammatory pseudotumor with rapid response to steroids: case report.27841882Shingu T, Ho AL, Yuan L, Zhou X, Dai C, Zheng S, Wang Q, Zhong Y, Chang Q, Horner JW, Liebelt BD, Yao Y, Hu B, Chen Y, Fuller GN, Verhaak RG, Heimberger AB, Hu JNature geneticsQki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nat Genet. 2017 01; 49(1):75-86.Nat Genet2016-11-14T00:00:002016Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.27863244Hu B, Wang Q, Wang YA, Hua S, Sauv? CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao WT, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RGW, DePinho RACellEpigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 2016 11 17; 167(5):1281-1295.e18.Cell2016-11-17T00:00:002016Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.19900287Humphries W, Wang Y, Qiao W, Reina-Ortiz C, Abou-Ghazal MK, Crutcher LM, Wei J, Kong LY, Sawaya R, Rao G, Weinberg J, Prabhu SS, Fuller GN, Heimberger ABJournal of translational medicineyuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients. J Transl Med. 2009 Nov 09; 7:92.J Transl Med2009-11-09T00:00:002009yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.20214040Heimberger AB, Kong LY, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Wei J, Qiao W, Schmittling RJ, Archer GE, Sampson JH, Hiraoka N, Priebe W, Fuller GN, Sawaya RClinical neurosurgeryThe role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clin Neurosurg. 2009; 56:98-106.Clin Neurosurg2009-01-01T00:00:002009The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.20388845Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchInhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Clin Cancer Res. 2010 May 01; 16(9):2550-61.Clin Cancer Res2010-04-13T00:00:002010Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.21167761Bell D, Gidley P, Levine N, Fuller GNAnnals of diagnostic pathologyEndolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience. Ann Diagn Pathol. 2011 Apr; 15(2):117-23.Ann Diagn Pathol2010-12-16T00:00:002010Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience.21171016Doucette T, Yang Y, Zhang W, Fuller GN, Suki D, Fults DW, Rao GInternational journal of cancerBcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma. Int J Cancer. 2011 Nov 01; 129(9):2093-103.Int J Cancer2011-03-04T00:00:002011Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.JASONHUSEJASON HUSE12747HUSE, JASONAssociate Professor20657231Kumar AJ, Leeds NE, Kumar VA, Fuller GN, Lang FF, Milas Z, Weinberg JS, Ater JL, Sawaya RJournal of computer assisted tomographyMagnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high-grade gliomas. J Comput Assist Tomogr. 2010 Jul; 34(4):601-11.J Comput Assist Tomogr2010-07-01T00:00:002010Magnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high-grade gliomas.21523764Singh A, Rokes C, Gireud M, Fletcher S, Baumgartner J, Fuller G, Stewart J, Zage P, Gopalakrishnan VCancerRetinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(?-TRCP) in neuroblastoma cells. Cancer. 2011 Nov 15; 117(22):5189-202.Cancer2011-04-26T00:00:002011Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(?-TRCP) in neuroblastoma cells.22753228Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, B?gler O, Heimberger AB, Rao GNeuro-oncologySignal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol. 2012 Sep; 14(9):1136-45.Neuro Oncol2012-06-29T00:00:002012Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.27874212Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BSAmerican journal of hematologyDorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol. 2017 Feb; 92(2):155-160.Am J Hematol2017-02-01T00:00:002017Dorsal column myelopathy after intrathecal chemotherapy for leukemia.26973881Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger ABJCI insightGlioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016; 1(2).JCI Insight2016-02-25T00:00:002016Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.21598070Xu J, Sampath D, Lang FF, Prabhu S, Rao G, Fuller GN, Liu Y, Puduvalli VKJournal of neuro-oncologyVorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures. J Neurooncol. 2011 Nov; 105(2):241-51.J Neurooncol2011-05-20T00:00:002011Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures.23298836Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, Li X, Gumin J, Zheng H, Hu L, Yli-Harja O, Haapasalo H, Visakorpi T, Liu X, Liu CG, Sawaya R, Fuller GN, Chen K, Lang FF, Nykter M, Zhang WThe Journal of clinical investigationThe tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest. 2013 Feb; 123(2):855-65.J Clin Invest2013-01-09T00:00:002013The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.21892765Li JY, Langford LA, Adesina A, Bodhireddy SR, Wang M, Fuller GNBrain tumor pathologyThe high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma. Brain Tumor Pathol. 2012 Jan; 29(1):68-72.Brain Tumor Pathol2011-09-03T00:00:002011The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma.Authorship 841194Authorship 841701Authorship 842718Authorship 844032Authorship 844275Authorship 844950Authorship 844970Authorship 846052Authorship 847096Authorship 847890Authorship 847904Authorship 848722Authorship 848933Authorship 849755Authorship 850784Authorship 850858Authorship 852049Authorship 854144Authorship 854565Authorship 854630Authorship 855331Authorship 855340Authorship 856033Authorship 856084Authorship 856770Authorship 857404Authorship 858350Authorship 858722Authorship 860672Authorship 860792Authorship 861263Authorship 863445Authorship 865856Authorship 866167Authorship 866169Authorship 866179Authorship 866391Authorship 86655928284220Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger ABMolecular cancerSerum microRNA profiling in patients with glioblastoma: a survival analysis. Mol Cancer. 2017 03 11; 16(1):59.Mol Cancer2017-03-11T00:00:002017Serum microRNA profiling in patients with glioblastoma: a survival analysis.Skull Base SurgeryComparison of the invasiveness profiles of en plaque and globoid meningiomas. Skull Base Surgery. 9:7.Comparison of the invasiveness profiles of en plaque and globoid meningiomasBrain PathologyIntroduction. Brain Pathology. 12:53.IntroductionAmerican Journal of Surgical PathologyPrimary Glial and Neuronal Tumors of the Ovary or Peritoneum. American Journal of Surgical Pathology. Primary Glial and Neuronal Tumors of the Ovary or PeritoneumFinding functional structures in glioma gene-expressions using gene shaving clustering and MDL principle. 89-118.Finding functional structures in glioma gene-expressions using gene shaving clustering and MDL principleCentral nervous system. Central nervous systemCellEpigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 167:1281-1295.e18.Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive GrowthActa NeuropathologicaGenetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathologica. 130:587-597.Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastomaNeurologyProgressive diffuse meningioangiomatosis. Neurology. 86:1643-1644.Progressive diffuse meningioangiomatosisBMC GenomicsObtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics. 3.Obtaining reliable information from minute amounts of RNA using cDNA microarraysBrain Metastases. 55-70.Brain MetastasesVirchows ArchivWhole-transcriptome analysis of chordoma of the skull base. Virchows Archiv. 1-11.Whole-transcriptome analysis of chordoma of the skull baseChinese Journal of CancerTumor-associated methylation of the putative tumor suppressor ajap1 gene and association between decreased ajap1 expression and shorter survival in patients with glioma. Chinese Journal of Cancer. 30:254-263.Tumor-associated methylation of the putative tumor suppressor ajap1 gene and association between decreased ajap1 expression and shorter survival in patients with gliomaOncogeneIGFBP2 potentiates nuclear EGFR-STAT3 signaling. Oncogene. 35:738-747.IGFBP2 potentiates nuclear EGFR-STAT3 signalingNeuro-OncologyPD-L1 expression and prognostic impact in glioblastoma. Neuro-Oncology. 18:195-205.PD-L1 expression and prognostic impact in glioblastomaJournal of Neuro-OncologyErratum to. Journal of Neuro-Oncology. 119:37.Erratum toOncotargetCdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma. Oncotarget. 7:26793-26805.Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastomaNeuro-OncologyMiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro-Oncology. 18:639-648.MiR-138 exerts anti-glioma efficacy by targeting immune checkpointsCancer ResearchmiR-182-5p induced by STAT3 activation promotes glioma tumorigenesis. Cancer Research. 76:4293-4304.miR-182-5p induced by STAT3 activation promotes glioma tumorigenesisNature GeneticsQki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nature Genetics. 49:75-86.Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradationStem CellsREST regulates oncogenic properties of glioblastoma stem cells (Stem Cells (2012) 30 (405-414) DOI. Stem Cells. 30:1049.REST regulates oncogenic properties of glioblastoma stem cells (Stem Cells (2012) 30 (405-414) DOIAnnals of Surgical OncologySarcoma Brain Metastases. Annals of Surgical Oncology. 1-6.Sarcoma Brain MetastasesBrain PathologyThe 2007 WHO classification of tumors of the nervous system. Brain Pathology. 18:640.The 2007 WHO classification of tumors of the nervous systemEpithelial, Neuroendocrine, and Metastatic Lesions. 287-313.Epithelial, Neuroendocrine, and Metastatic LesionsDevelopmental Brain ResearchDifferential growth recovery within the brains of postnatally undernourished rats. Developmental Brain Research. 15:280-282.Differential growth recovery within the brains of postnatally undernourished ratsJournal of Neuro-OncologyImpact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. Journal of Neuro-Oncology. 1-8.Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastomaMolecular diagnosis of glioma. 520-527.Molecular diagnosis of gliomaModern PathologyGliomatosis peritonei. Modern Pathology. 1613-1620.Gliomatosis peritoneiNeuro-OncologyImmune checkpoint blockade as a potential therapeutic target. Neuro-Oncology. 18:1357-1366.Immune checkpoint blockade as a potential therapeutic targetOncotargetDriver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Oncotarget. 7:23521-23529.Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesisIntraoperative Consultation and Optimal Processing. 35-45.Intraoperative Consultation and Optimal ProcessingArchives of Pathology and Laboratory MedicineBrain tumors. Archives of Pathology and Laboratory Medicine. 131:225-227.Brain tumorsAmerican Journal of HematologyDorsal column myelopathy after intrathecal chemotherapy for leukemia. American Journal of Hematology. 92:155-160.Dorsal column myelopathy after intrathecal chemotherapy for leukemiaOncoImmunologyTipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. OncoImmunology. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppressionOncogeneThe deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation. Oncogene. The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferationCancer ResearchPINK1 is a negative regulator of growth and the warburg effect in glioblastoma. Cancer Research. 76:4708-4719.PINK1 is a negative regulator of growth and the warburg effect in glioblastomaMutation Research - Reviews in Mutation ResearchAmplified cellular oncogenes in neoplasms of the human central nervous system. Mutation Research - Reviews in Mutation Research. 276:299-306.Amplified cellular oncogenes in neoplasms of the human central nervous systemBrain PathologyMitotic index is an independent predictor of recurrence-free survival in meningioma. Brain Pathology. 25:266-275.Mitotic index is an independent predictor of recurrence-free survival in meningiomaJournal of NeuroscienceMir-21-Sox2 axis delineates glioblastoma subtypes with prognostic impact. Journal of Neuroscience. 35:15097-15112.Mir-21-Sox2 axis delineates glioblastoma subtypes with prognostic impact23013619de Groot J, Liang J, Kong LY, Wei J, Piao Y, Fuller G, Qiao W, Heimberger ABOncotargetModulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma. Oncotarget. 2012 Sep; 3(9):1036-48.Oncotarget2012-09-01T00:00:002012Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.28395087Ballester LY, Fuller GN, Powell SZ, Sulman EP, Patel KP, Luthra R, Routbort MJJournal of neuropathology and experimental neurologyRetrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors. J Neuropathol Exp Neurol. 2017 03 01; 76(3):179-188.J Neuropathol Exp Neurol2017-03-01T00:00:002017Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors.28453745Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FFNeuro-oncologyPercentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 2017 05 01; 19(5):660-668.Neuro Oncol2017-05-01T00:00:002017Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.12816727Lee HK, Chang EL, Fuller GN, Aldape KD, Atkinson GJ, Levy LB, McCutcheon IE, Maor MHNeuro-oncologyThe prognostic value of neurologic function in astrocytic spinal cord glioma. Neuro Oncol. 2003 07; 5(3):208-13.Neuro Oncol2003-07-01T00:00:002003The prognostic value of neurologic function in astrocytic spinal cord glioma.28807937Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, Tong X, Tannir NM, Matin SF, Rathmell WK, Fuller GN, McCutcheon IE, Walker CL, Wang J, Jonasch ECancer researchHNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326.Cancer Res2017-08-14T00:00:002017HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.15489659Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GNThe American journal of surgical pathologyThe mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004 Nov; 28(11):1532-6.Am J Surg Pathol2004-11-01T00:00:002004The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.15671555Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli MClinical cancer research : an official journal of the American Association for Cancer ResearchLoss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res. 2005 Jan 01; 11(1):267-72.Clin Cancer Res2005-01-01T00:00:002005Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.15692944Neto AG, McCutcheon IE, Vang R, Spencer ML, Zhang W, Fuller GNAnnals of diagnostic pathologyElevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomas. Ann Diagn Pathol. 2005 Feb; 9(1):6-10.Ann Diagn Pathol2005-02-01T00:00:002005Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomas.16156899McDonald JM, Dunmire V, Taylor E, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang WMolecular cancerAttenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss. Mol Cancer. 2005 Sep 12; 4:35.Mol Cancer2005-09-12T00:00:002005Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss.16284546Patel AJ, Fuller GN, Wildrick DM, Sawaya RNeurosurgeryPineal cyst apoplexy: case report and review of the literature. Neurosurgery. 2005 Nov; 57(5):E1066; discussion E1066.Neurosurgery2005-11-01T00:00:002005Pineal cyst apoplexy: case report and review of the literature.16575014Wang L, Wei Q, Wang LE, Aldape KD, Cao Y, Okcu MF, Hess KR, El-Zein R, Gilbert MR, Woo SY, Prabhu SS, Fuller GN, Bondy MLJournal of clinical oncology : official journal of the American Society of Clinical OncologySurvival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol. 2006 Apr 01; 24(10):1627-32.J Clin Oncol2006-04-01T00:00:002006Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.16594739Leeds NE, Lang FF, Ribalta T, Sawaya R, Fuller GNArchives of pathology & laboratory medicineOrigin of chordoid glioma of the third ventricle. Arch Pathol Lab Med. 2006 Apr; 130(4):460-4.Arch Pathol Lab Med2006-04-01T00:00:002006Origin of chordoid glioma of the third ventricle.16619307Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, Tabus I, Aldape K, Sawaya R, Bruner JM, Fuller GN, Zhang WProteomicsPathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics. 2006 May; 6(10):2964-71.Proteomics2006-05-01T00:00:002006Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.16729015Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu JModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncInsulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006 Sep; 19(9):1149-56.Mod Pathol2006-05-26T00:00:002006Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types.16790091Lee OH, Fueyo J, Xu J, Yung WK, Lemoine MG, Lang FF, Bekele BN, Zhou X, Alonso MA, Aldape KD, Fuller GN, Gomez-Manzano CNeoplasia (New York, N.Y.)Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia. 2006 May; 8(5):419-28.Neoplasia2006-05-01T00:00:002006Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth.16818690Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, Fuller GN, Aldape KDClinical cancer research : an official journal of the American Association for Cancer ResearchPrognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res. 2006 Jul 01; 12(13):3935-41.Clin Cancer Res2006-07-01T00:00:002006Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.17803030McCutcheon IE, Waguespack SG, Fuller GN, Couldwell WTThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiquesMetastatic melanoma to the pituitary gland. Can J Neurol Sci. 2007 Aug; 34(3):322-7.Can J Neurol Sci2007-08-01T00:00:002007Metastatic melanoma to the pituitary gland.18196230Yoo JH, Rivera A, Naeini RM, Yedururi S, Bayindir P, Megahead H, Fuller GN, Suh JS, Adesina AM, Hunter JVPediatric radiologyMelanotic paraganglioma arising in the temporal horn following Langerhans cell histiocytosis. Pediatr Radiol. 2008 May; 38(5):571-4.Pediatr Radiol2008-01-15T00:00:002008Melanotic paraganglioma arising in the temporal horn following Langerhans cell histiocytosis.18338396Amini E, Roffidal T, Lee A, Fuller GN, Mahajan A, Ketonen L, Kobrinsky N, Cairo MS, Wells RJ, Wolff JEPediatric blood & cancerCentral neurocytoma responsive to topotecan, ifosfamide, carboplatin. Pediatr Blood Cancer. 2008 Jul; 51(1):137-40.Pediatr Blood Cancer2008-07-01T00:00:002008Central neurocytoma responsive to topotecan, ifosfamide, carboplatin.18794085Kong LY, Abou-Ghazal MK, Wei J, Chakraborty A, Sun W, Qiao W, Fuller GN, Fokt I, Grimm EA, Schmittling RJ, Archer GE, Sampson JH, Priebe W, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchA novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells. Clin Cancer Res. 2008 Sep 15; 14(18):5759-68.Clin Cancer Res2008-09-15T00:00:002008A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.21283755Wei J, Wu A, Kong LY, Wang Y, Fuller G, Fokt I, Melillo G, Priebe W, Heimberger ABPloS oneHypoxia potentiates glioma-mediated immunosuppression. PLoS One. 2011 Jan 20; 6(1):e16195.PLoS One2011-01-20T00:00:002011Hypoxia potentiates glioma-mediated immunosuppression.22120760Hightower E, Cabanillas ME, Fuller GN, McCutcheon IE, Hess KR, Shah K, Waguespack SG, Corley LJ, Devin JKPituitaryPhospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas. Pituitary. 2012 Dec; 15(4):556-61.Pituitary2012-12-01T00:00:002012Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.22197544Olar A, Raghunathan A, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Goodman JC, Fuller GNAnnals of diagnostic pathologyAbsence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol. 2012 Jun; 16(3):161-70.Ann Diagn Pathol2011-12-24T00:00:002011Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults.22228704Kamal MM, Sathyan P, Singh SK, Zinn PO, Marisetty AL, Liang S, Gumin J, El-Mesallamy HO, Suki D, Colman H, Fuller GN, Lang FF, Majumder SStem cells (Dayton, Ohio)REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells. 2012 Mar; 30(3):405-14.Stem Cells2012-03-01T00:00:002012REST regulates oncogenic properties of glioblastoma stem cells.22488042Lee I, Fox PS, Ferguson SD, Bassett R, Kong LY, Schacherer CW, Gershenwald JE, Grimm EA, Fuller GN, Heimberger ABOncotargetThe expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival. Oncotarget. 2012 Mar; 3(3):336-44.Oncotarget2012-03-01T00:00:002012The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.22808300Li JY, Lopez JI, Powell SZ, Coons SW, Fuller GNInternational journal of clinical and experimental pathologyGiant cell ependymoma-report of three cases and review of the literature. Int J Clin Exp Pathol. 2012; 5(5):458-62.Int J Clin Exp Pathol2012-05-05T00:00:002012Giant cell ependymoma-report of three cases and review of the literature.29280764Boulter TD, Sadaka A, Nakawah MO, Smith SV, Alouch N, Berry SE, Whyte AT, Fuller GN, Lee AGJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyPrimary Central Nervous System Lymphoma With Light Chain Deposition Disease (Aggregoma). J Neuroophthalmol. 2018 Jun; 38(2):195-197.J Neuroophthalmol2018-06-01T00:00:002018Primary Central Nervous System Lymphoma With Light Chain Deposition Disease (Aggregoma).29432077Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, Prabhu SS, Rao G, Fuller GN, Aldape KD, Gumin J, Vence LM, Wistuba I, Rodriguez-Canales J, Villalobos PA, Dirven CMF, Tejada S, Valle RD, Alonso MM, Ewald B, Peterkin JJ, Tufaro F, Fueyo JJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018 05 10; 36(14):1419-1427.J Clin Oncol2018-02-12T00:00:002018Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.29509313Ballester LY, Boghani Z, Baskin DS, Britz GW, Olsen R, Fuller GN, Powell SZ, Cykowski MDBrain pathology (Zurich, Switzerland)Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins. Brain Pathol. 2018 11; 28(6):1012-1019.Brain Pathol2018-04-25T00:00:002018Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins.29328002Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn POJournal of neurosurgeryDexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018 12 01; 129(6):1446-1455.J Neurosurg2018-12-01T00:00:002018Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.23532501Tahmasebi FC, Farmer P, Powell SZ, Aldape KD, Fuller GN, Patel S, Hollis P, Chalif D, Eisenberg MB, Li JYVirchows Archiv : an international journal of pathologyBrain metastases from papillary thyroid carcinomas. Virchows Arch. 2013 Apr; 462(4):473-80.Virchows Arch2013-03-27T00:00:002013Brain metastases from papillary thyroid carcinomas.Authorship 88774229Authorship 8879055Authorship 88800515Authorship 88840621Authorship 8884434Authorship 8886127Authorship 8888578Authorship 8888969Authorship 8891066Authorship 8891929Authorship 8897992Authorship 88980811Authorship 88982619Authorship 8902298D016543Disorders2295020.685613Central Nervous System NeoplasmsD001932Disorders88848480.292739Brain NeoplasmsD018971Chemicals & Drugs55890.944443Insulin-Like Growth Factor Binding Protein 2D005910Disorders38619630.43438Glioma27270908Mandel JJ, Cachia D, Liu D, Wilson C, Aldape K, Fuller G, de Groot JFJournal of neuro-oncologyImpact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.J Neurooncol2016-06-07T00:00:002016Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.Authorship 9049353Authorship 90533915Authorship 9054664Authorship 9057938Authorship 90625412Authorship 9077876Authorship 90931211Authorship 9093164Authorship 9094572Authorship 91042712Authorship 9110944Authorship 9114225Authorship 9117337Authorship 9120504Authorship 91658612Authorship 9181604Authorship 9184167Authorship 9194387Authorship 9207923Authorship 9263477Authorship 9269225Authorship 9270236Authorship 9283574Authorship 9293994Authorship 9298927Authorship 9304437Authorship 93060012Authorship 9314067Authorship 93185813Authorship 9324007Authorship 9350005Authorship 93552312Authorship 93663112Authorship 93776125Authorship 9393647Authorship 9395561326323609Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks JK, Fuller GN, Calin GA, Conrad CA, Creasy C, Ritthipichai K, Radvanyi L, Heimberger ABNeuro-oncologyPD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 2016 Feb; 18(2):195-205.Neuro Oncol2015-08-30T00:00:002015PD-L1 expression and prognostic impact in glioblastoma.27074575Gressot LV, Doucette T, Yang Y, Fuller GN, Manyam G, Rao A, Latha K, Rao GOncotargetAnalysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma. Oncotarget. 2017 Feb 21; 8(8):12695-12704.Oncotarget2017-02-21T00:00:002017Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.26658052Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, Ivan C, Fuller GN, Gilbert MR, Overwijk W, Calin GA, Heimberger ABNeuro-oncologyMiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol. 2016 05; 18(5):639-48.Neuro Oncol2015-12-11T00:00:002015MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.27029633Yust-Katz S, Fuller G, Fichman-Horn S, Michaeli N, Inbar E, Lukman J, Limon D, Steiner I, Siegal TNeurologyProgressive diffuse meningioangiomatosis: Response to bevacizumab treatment. Neurology. 2016 04 26; 86(17):1643-4.Neurology2016-03-30T00:00:002016Progressive diffuse meningioangiomatosis: Response to bevacizumab treatment.27370400Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger ABNeuro-oncologyImmune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol. 2016 10; 18(10):1357-66.Neuro Oncol2016-07-01T00:00:002016Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.27646022Al Sannaa G, Watson KL, Olar A, Wang WL, Fuller GN, McCutcheon I, Torres KE, Lazar AJAnnals of surgical oncologySarcoma Brain Metastases: 28?Years of Experience at a Single Institution. Ann Surg Oncol. 2016 12; 23(Suppl 5):962-967.Ann Surg Oncol2016-09-19T00:00:002016Sarcoma Brain Metastases: 28?Years of Experience at a Single Institution.27125842Phillips LM, Zhou X, Cogdell DE, Chua CY, Huisinga A, R Hess K, Fuller GN, Zhang WThe Journal of pathologyGlioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies. J Pathol. 2016 07; 239(3):355-64.J Pathol2016-06-10T00:00:002016Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.26990854Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian XW, Yang W, Zhang J, Yemelyanova A, Malpica A, Zhang Z, Fuller GN, Liu JThe American journal of surgical pathologyPrimary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56.Am J Surg Pathol2016-06-01T00:00:002016Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.26993778Ji P, Zhou X, Liu Q, Fuller GN, Phillips LM, Zhang WOncotargetDriver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Oncotarget. 2016 Apr 26; 7(17):23521-9.Oncotarget2016-04-26T00:00:002016Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.27050366Park SY, Piao Y, Thomas C, Fuller GN, de Groot JFOncotargetCdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma. Oncotarget. 2016 May 03; 7(18):26793-805.Oncotarget2016-05-03T00:00:002016Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma.27325644Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, Rakopoulos P, Ramaswamy V, Taccone MS, Mischel PS, Fuller GN, Hawkins C, Stanford WL, Taylor MD, Zadeh G, Rutka JTCancer researchPINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Res. 2016 08 15; 76(16):4708-19.Cancer Res2016-06-20T00:00:002016PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma.27401718Bell D, Raza SM, Bell AH, Fuller GN, DeMonte FVirchows Archiv : an international journal of pathologyWhole-transcriptome analysis of chordoma of the skull base. Virchows Arch. 2016 Oct; 469(4):439-49.Virchows Arch2016-07-11T00:00:002016Whole-transcriptome analysis of chordoma of the skull base.27467917Kong LY, Wei J, Fuller GN, Schrand B, Gabrusiewicz K, Zhou S, Rao G, Calin G, Gilboa E, Heimberger ABOncoimmunologyTipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. Oncoimmunology. 2016 May; 5(5):e1117739.Oncoimmunology2015-12-21T00:00:002015Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression.28178009Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PPThe American Journal of dermatopathologyIsolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. Am J Dermatopathol. 2017 Jul; 39(7):545-547.Am J Dermatopathol2017-07-01T00:00:002017Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor.28382223Powell RT, Olar A, Narang S, Rao G, Sulman E, Fuller GN, Rao AJournal of pathology informaticsIdentification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas. J Pathol Inform. 2017; 8:9.J Pathol Inform2017-03-10T00:00:002017Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.28549927Ballester LY, Huse JT, Tang G, Fuller GNHuman pathologyMolecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results. Hum Pathol. 2017 11; 69:15-22.Hum Pathol2017-05-23T00:00:002017Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results.29131126Gilbert AR, Zaky W, Gokden M, Fuller CE, Ocal E, Leeds NE, Fuller GNPediatric neurosurgeryExtending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin. Pediatr Neurosurg. 2018; 53(1):59-63.Pediatr Neurosurg2017-11-04T00:00:002017Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin.28844110Bell AH, DeMonte F, Raza SM, Rhines LD, Tatsui CE, Prieto VG, Fuller GN, Bell DVirchows Archiv : an international journal of pathologyTranscriptome comparison identifies potential biomarkers of spine and skull base chordomas. Virchows Arch. 2018 Mar; 472(3):489-497.Virchows Arch2017-08-27T00:00:002017Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.29040778Raza SM, Bell D, Freeman JL, Grosshans DR, Fuller GN, DeMonte FOperative neurosurgery (Hagerstown, Md.)Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival. Oper Neurosurg (Hagerstown). 2018 08 01; 15(2):131-143.Oper Neurosurg (Hagerstown)2018-08-01T00:00:002018Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival.29610389Ballester LY, Penas-Prado M, Leeds NE, Huse JT, Fuller GNCold Spring Harbor molecular case studiesFGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia. Cold Spring Harb Mol Case Stud. 2018 04; 4(2).Cold Spring Harb Mol Case Stud2018-04-02T00:00:002018FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia.29805741Pili? P, Hasanov E, Matin SF, Woodson AHH, Marcott VD, Bird S, Slack RS, Fuller GN, McCutcheon IE, Jonasch EOncotargetPilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget. 2018 May 04; 9(34):23390-23395.Oncotarget2018-05-04T00:00:002018Pilot study of dovitinib in patients with von Hippel-Lindau disease.29632728Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, Dunner K, Zal MA, Burks JK, Gumin J, Nwajei F, Rezavanian A, Zhou S, Rao G, Sawaya R, Fuller GN, Huse JT, Antel JP, Li S, Cooper L, Sulman EP, Chen C, Geula C, Kalluri R, Zal T, Heimberger ABOncoimmunologyGlioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology. 2018; 7(4):e1412909.Oncoimmunology2018-01-16T00:00:002018Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.30210430Ballester LY, Dunbar E, Guha-Thakurta N, Henson JW, Chandler H, Watkins J, Fuller GNFrontiers in neurologyPrimary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted. Front Neurol. 2018; 9:700.Front Neurol2018-08-27T00:00:002018Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted.29991240Beechar VB, Zinn PO, Heck KA, Fuller GN, Han I, Patel AJ, Ropper AENeurospineSpinal Epidermoid Tumors: Case Report and Review of the Literature. Neurospine. 2018 Jun; 15(2):117-122.Neurospine2018-06-19T00:00:002018Spinal Epidermoid Tumors: Case Report and Review of the Literature.30054278Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, de Groot JF, Baladandayuthapani V, Sulman EP, Kumar AJ, Sawaya R, Lang FF, Piwnica-Worms D, Colen RRClinical cancer research : an official journal of the American Association for Cancer ResearchA Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 12 15; 24(24):6288-6299.Clin Cancer Res2018-07-27T00:00:002018A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.30064493Du D, Yuan J, Ma W, Ning J, Weinstein JN, Yuan X, Fuller GN, Liu YBMC cancerClinical significance of FBXO17 gene expression in high-grade glioma. BMC Cancer. 2018 Jul 31; 18(1):773.BMC Cancer2018-07-31T00:00:002018Clinical significance of FBXO17 gene expression in high-grade glioma.29797626Wang B, Gogia B, Fuller GN, Ketonen LMJournal of neuroimaging : official journal of the American Society of NeuroimagingEmbryonal Tumor with Multilayered Rosettes, C19MC-Altered: Clinical, Pathological, and Neuroimaging Findings. J Neuroimaging. 2018 09; 28(5):483-489.J Neuroimaging2018-05-24T00:00:002018Embryonal Tumor with Multilayered Rosettes, C19MC-Altered: Clinical, Pathological, and Neuroimaging Findings.30046660Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Undiagnosed Diseases Network, Dhar SUNeurology. GeneticsAtypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248.Neurol Genet2018-07-20T00:00:002018Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma.30108242Lu L, Marisetty A, Liu B, Kamal MM, Gumin J, Veo B, Cai Y, Kassem DH, Weng C, Maynard ME, Hood KN, Fuller GN, Pan ZZ, Cykowski MD, Dash PK, Majumder SScientific reportsREST overexpression in mice causes deficits in spontaneous locomotion. Sci Rep. 2018 08 14; 8(1):12083.Sci Rep2018-08-14T00:00:002018REST overexpression in mice causes deficits in spontaneous locomotion.30236511Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SFThe Lancet. OncologyPazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359.Lancet Oncol2018-09-17T00:00:002018Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.30307407Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, Grami Z, Kong LY, Ling X, Caruso H, Zhou S, Wang YA, Fuller GN, Huse J, Gilboa E, Kang N, Huang X, Verhaak R, Li S, Heimberger ABThe Journal of clinical investigationOsteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. J Clin Invest. 2019 01 02; 129(1):137-149.J Clin Invest2018-11-19T00:00:002018Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.29706304Lewis GD, Jonasch E, Shah AY, Fuller GN, Farach AM, Butler EB, Teh BSPractical radiation oncologyRenal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literature. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e262-e265.Pract Radiat Oncol2018-03-10T00:00:002018Renal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literature.29947810Latha K, Yan J, Yang Y, Gressot LV, Kong LY, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Eric Davis R, Huang S, Fuller GN, Rao A, Heimberger AB, Li S, Rao GJournal of the National Cancer InstituteThe Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. J Natl Cancer Inst. 2019 03 01; 111(3):292-300.J Natl Cancer Inst2019-03-01T00:00:002019The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.30657997Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout DNeuro-oncologyGuiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging. Neuro Oncol. 2019 03 18; 21(4):527-536.Neuro Oncol2019-03-18T00:00:002019Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging.30499772Olar A, Tran D, Mehta VP, Reinhardt A, Manekia JH, Garnovskaya M, Ellezam B, Luthra R, Sulman EP, Mohila CA, Campbell GA, Powell SZ, Fuller GN, Aldape KD, Adesina AMClinical neuropathologyATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clin Neuropathol. 2019 Mar/Apr; 38(2):59-73.Clin Neuropathol2019-03-01T00:00:002019ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features.D005909Disorders40318030.447986GlioblastomaNeurosurgeryPathologyDepartment of NeurosurgeryNeurosurgeryBaylor College of MedicineFREDERICKLANGFREDERICK LANG29.70706480000000-95.397162400000001037LANG, FREDERICKAdjunct ProfessorAuthorship 940889530803556Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado MCancer geneticsRBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report. Cancer Genet. 2019 02; 231-232:41-45.Cancer Genet2019-01-09T00:00:002019RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report.Authorship 943386930926639Zheng S, Alfaro-Munoz K, Wei W, Wang X, Wang F, Eterovic AK, Shaw KRM, Meric-Bernstam F, Fuller GN, Chen K, Verhaak RG, Mills GB, Yung WKA, Weathers SP, de Groot JFMolecular cancer therapeuticsProspective Clinical Sequencing of Adult Glioma. Mol Cancer Ther. 2019 05; 18(5):991-1000.Mol Cancer Ther2019-03-29T00:00:002019Prospective Clinical Sequencing of Adult Glioma.Authorship 9446791630953587Marisetty AL, Lu L, Veo BL, Liu B, Coarfa C, Kamal MM, Kassem DH, Irshad K, Lu Y, Gumin J, Henry V, Paulucci-Holthauzen A, Rao G, Baladandayuthapani V, Lang FF, Fuller GN, Majumder SNeuro-oncologyREST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019 06 10; 21(6):775-785.Neuro Oncol2019-06-10T00:00:002019REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.Authorship 946372531036092Ballester LY, Moghadamtousi SZ, Leeds NE, Huse JT, Fuller GNActa neuropathologica communicationsCoexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases. Acta Neuropathol Commun. 2019 04 29; 7(1):63.Acta Neuropathol Commun2019-04-29T00:00:002019Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases.19894022Hassaneen W, Cahill DP, Fuller GN, Levine NBJournal of neuro-oncologyImmunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma. J Neurooncol. 2010 May; 98(1):151-2.J Neurooncol2009-11-06T00:00:002009Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma.23636127Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger ABCancer researchmiR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26.Cancer Res2013-05-01T00:00:002013miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.Authorship 950933731258848Georgescu MM, Li Y, Islam MZ, Notarianni C, Sun H, Olar A, Fuller GNOncotargetMutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications. Oncotarget. 2019 Jun 18; 10(40):4038-4052.Oncotarget2019-06-18T00:00:002019Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications.Authorship 9522081431320621Elshafeey N, Kotrotsou A, Hassan A, Elshafei N, Hassan I, Ahmed S, Abrol S, Agarwal A, El Salek K, Bergamaschi S, Acharya J, Moron FE, Law M, Fuller GN, Huse JT, Zinn PO, Colen RRNature communicationsMulticenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun. 2019 07 18; 10(1):3170.Nat Commun2019-07-18T00:00:002019Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma.Authorship 952659831349217Santos-Pinheiro F, Penas-Prado M, Kamiya-Matsuoka C, Waguespack SG, Mahajan A, Brown PD, Shah KB, Fuller GN, McCutcheon IEEuropean journal of endocrinologyTreatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol. 2019 Oct; 181(4):397-407.Eur J Endocrinol2019-10-01T00:00:002019Treatment and long-term outcomes in pituitary carcinoma: a cohort study.Authorship 9614351531755915de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger ABNeuro-oncologyWindow-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.Neuro Oncol2020-04-15T00:00:002020Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.Authorship 9750401031888886Chen Y, Fang R, Yue C, Chang G, Li P, Guo Q, Wang J, Zhou A, Zhang S, Fuller GN, Shi X, Huang SCancer researchWnt-Induced Stabilization of KDM4C Is Required for Wnt/?-Catenin Target Gene Expression and Glioblastoma Tumorigenesis. Cancer Res. 2020 03 01; 80(5):1049-1063.Cancer Res2019-12-30T00:00:002019Wnt-Induced Stabilization of KDM4C Is Required for Wnt/?-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.Authorship 975510331925333Li T, Forbes ME, Fuller GN, Li J, Yang X, Zhang WOncogeneIGFBP2: integrative hub of developmental and oncogenic signaling network. Oncogene. 2020 03; 39(11):2243-2257.Oncogene2020-01-10T00:00:002020IGFBP2: integrative hub of developmental and oncogenic signaling network.Authorship 976695531996992Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C, Holland EC, Jenkins RB, Kleinschmidt-DeMasters B, Komori T, Kros JM, Louis DN, McLean C, Perry A, Reifenberger G, Sarkar C, Stupp R, van den Bent MJ, von Deimling A, Weller MActa neuropathologicacIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol. 2020 03; 139(3):603-608.Acta Neuropathol2020-01-29T00:00:002020cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.Authorship 977373732016322Ballester LY, Meis JM, Lazar AJ, Prabhu SS, Hoang KB, Leeds NE, Fuller GNJournal of neuropathology and experimental neurologyIntracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. J Neuropathol Exp Neurol. 2020 03 01; 79(3):347-351.J Neuropathol Exp Neurol2020-03-01T00:00:002020Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.true1Adjunct ProfessorAdjunct ProfessorAuthorship 98750816Authorship 987685832299815Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchGlioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res. 2020 07 15; 26(14):3565-3577.Clin Cancer Res2020-04-16T00:00:002020Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.32307792Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M, Fuller GN, Giannini C, Haberler C, Hawkins C, Komori T, Kros JM, Ng HK, Orr BA, Park SH, Paulus W, Perry A, Pietsch T, Reifenberger G, Rosenblum M, Rous B, Sahm F, Sarkar C, Solomon DA, Tabori U, van den Bent MJ, von Deimling A, Weller M, White VA, Ellison DWBrain pathology (Zurich, Switzerland)cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 2020 07; 30(4):844-856.Brain Pathol2020-04-19T00:00:002020cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.Authorship 988528132186609Araneda P, Sujima E, Paredes-Manzo P, Vallejo R, Valdivia F, Sinning M, Gallegos M, Fuller GRevista medica de Chile[H3K27 positive diffuse midline glioma. Report of one case]. Rev Med Chil. 2019 Nov; 147(11):1487-1490.Rev Med Chil2019-11-01T00:00:002019[H3K27 positive diffuse midline glioma. Report of one case].Authorship 9921031232554515Rao G, Latha K, Ott M, Sabbagh A, Marisetty A, Ling X, Zamler D, Doucette TA, Yang Y, Kong LY, Wei J, Fuller GN, Benavides F, Sonabend AM, Long J, Li S, Curran M, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchAnti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells. Clin Cancer Res. 2020 09 01; 26(17):4699-4712.Clin Cancer Res2020-06-18T00:00:002020Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.Authorship 9930841732605912Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler D, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski RJ, Burks JK, Long JP, Kong LY, Fuller GN, DeGroot J, Sulman EP, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchRadiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clin Cancer Res. 2020 09 15; 26(18):4983-4994.Clin Cancer Res2020-06-30T00:00:002020Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.Authorship 9955681032721947Ott M, Tomaszowski KH, Marisetty A, Kong LY, Wei J, Duna M, Blumberg K, Ji X, Jacobs C, Fuller GN, Langford LA, Huse JT, Long JP, Hu J, Li S, Weinberg JS, Prabhu SS, Sawaya R, Ferguson S, Rao G, Lang FF, Curran MA, Heimberger ABJCI insightProfiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight. 2020 09 03; 5(17).JCI Insight2020-09-03T00:00:002020Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.Authorship 996061732747747Bashour SI, Ibrahim NK, Schomer DF, Hess KR, Gao C, Tripathy D, Fuller GNBritish journal of cancerCentral nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype. Br J Cancer. 2020 10; 123(9):1417-1423.Br J Cancer2020-08-04T00:00:002020Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.Authorship 998626832882694Mullarkey MP, Nehme G, Mohiuddin S, Ballester LY, Bhattacharjee MB, Trivedi D, Shah MN, Fuller GN, Zaky W, Sandberg DIPediatric neurosurgeryPosttreatment Maturation of Medulloblastoma into Gangliocytoma: Report of 2 Cases. Pediatr Neurosurg. 2020; 55(4):222-231.Pediatr Neurosurg2020-09-03T00:00:002020Posttreatment Maturation of Medulloblastoma into Gangliocytoma: Report of 2 Cases.Authorship 999558632927372Bell D, Bell A, Ferrarotto R, Glisson B, Takahashi Y, Fuller G, Weber R, Hanna EAnnals of diagnostic pathologyHigh-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol. 2020 Dec; 49:151622.Ann Diagn Pathol2020-09-07T00:00:002020High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome.Authorship 999842232956231Wheelock-Gutierrez L, Harish Bindiganavile S, Ch?vez-Barrios P, Fuller GN, Bhat N, Lee AGJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyJuxtaposed Homonymous Hemianopsia Due to Neurotuberculosis. J Neuroophthalmol. 2021 Sep 01; 41(3):e303-e306.J Neuroophthalmol2021-09-01T00:00:002021Juxtaposed Homonymous Hemianopsia Due to Neurotuberculosis.Authorship 1007252533312675Nam JY, Gilbert A, Cachia D, Mandel J, Fuller GN, Penas-Prado M, de Groot J, Kamiya-Matsuoka CNeuro-oncology practicePineal parenchymal tumor of intermediate differentiation: a single-institution experience. Neurooncol Pract. 2020 Dec; 7(6):613-619.Neurooncol Pract2020-05-12T00:00:002020Pineal parenchymal tumor of intermediate differentiation: a single-institution experience.Authorship 1008672833426529Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, de Groot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger ABNeuro-oncology advancesA validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdaa146.Neurooncol Adv2020-10-31T00:00:002020A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.Authorship 1017415833931525Aaroe AE, Glitza Oliva IC, Al-Zubidi N, Nader ME, Kaya D, Ferguson SD, Wang C, Fuller G, Harrison RANeurologyPearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology. 2021 08 03; 97(5):248-250.Neurology2021-04-30T00:00:002021Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis.Authorship 1027484734377987Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Garcia MM, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado MNeuro-oncology advancesClinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab079.Neurooncol Adv2021-06-22T00:00:002021Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.Authorship 1030607334570201Melendez-Zaidi AE, Ou A, Fuller GNJAMA neurologyCarcinomatosis Encephalitis Secondary to Neuroendocrine Transformation of Prostate Cancer. JAMA Neurol. 2021 11 01; 78(11):1391-1392.JAMA Neurol2021-11-01T00:00:002021Carcinomatosis Encephalitis Secondary to Neuroendocrine Transformation of Prostate Cancer.Authorship 1031951934685601Salzillo TC, Mawoneke V, Weygand J, Shetty A, Gumin J, Zacharias NM, Gammon ST, Piwnica-Worms D, Fuller GN, Logothetis CJ, Lang FF, Bhattacharya PKCellsMeasuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells. 2021 10 01; 10(10).Cells2021-10-01T00:00:002021Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance.Authorship 1033879334752739Jaroudi S, Faiz SA, Fuller G, Rubio DThe American journal of the medical sciencesSpinal cord compression revealing metastatic cancer. Am J Med Sci. 2022 06; 363(6):e56-e57.Am J Med Sci2021-11-06T00:00:002021Spinal cord compression revealing metastatic cancer.Authorship 1036813934997889Wolff JE, Van Gool SW, Kutluk T, Diez B, Kebudi R, Timmermann B, Garami M, Sterba J, Fuller GN, Bison B, Kordes URJournal of neuro-oncologyFinal results of the Choroid Plexus Tumor study CPT-SIOP-2000. J Neurooncol. 2022 Feb; 156(3):599-613.J Neurooncol2022-01-08T00:00:002022Final results of the Choroid Plexus Tumor study CPT-SIOP-2000.Authorship 103869016Authorship 103899610Authorship 1039202535101778Amer A, Khose S, Alhasan H, Pokhylevych H, Fuller G, Chasen N, de Groot J, Johnson JMClinical neurology and neurosurgeryClinical and survival characteristics of primary and secondary gliosarcoma patients. Clin Neurol Neurosurg. 2022 03; 214:107146.Clin Neurol Neurosurg2022-01-29T00:00:002022Clinical and survival characteristics of primary and secondary gliosarcoma patients.35083579Shepard MJ, Haider AS, Prabhu SS, Sawaya R, DeMonte F, McCutcheon IE, Weinberg JS, Ferguson SD, Suki D, Fuller GN, Lang FFJournal of neuro-oncologyLong term outcomes following surgery for pineal region tumors. J Neurooncol. 2022 Feb; 156(3):491-498.J Neurooncol2022-01-27T00:00:002022Long term outcomes following surgery for pineal region tumors.35316217Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, Huse JT, Fuller GN, Long JP, Winkowski DE, Freiberg BA, James CD, Platanias LC, Lesniak MS, Burks JK, Heimberger ABJCI insightCentral nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. JCI Insight. 2022 05 09; 7(9).JCI Insight2022-05-09T00:00:002022Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression.Authorship 1043953835426054Haider AS, El Ahmadieh TY, Haider M, Hatanpaa KJ, Pinho MC, Mickey BE, Sawaya R, Fuller GN, Schomer DF, Gule-Monroe MNeuroradiologyImaging characteristics of 4th ventricle subependymoma. Neuroradiology. 2022 Sep; 64(9):1795-1800.Neuroradiology2022-04-15T00:00:002022Imaging characteristics of 4th ventricle subependymoma.Authorship 1045105535509530Gopakumar S, McDonald MF, Sharma H, Tatsui CE, Fuller GN, Rao GSurgical neurology internationalRecurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification. Surg Neurol Int. 2022; 13:139.Surg Neurol Int2022-04-15T00:00:002022Recurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification.Authorship 10460201135575067Groot J, Ott M, Wei J, Kassab C, Fang D, Najem H, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, DeCuypere M, Heimberger ABCNS oncologyA first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. CNS Oncol. 2022 06 01; 11(2):CNS87.CNS Oncol2022-05-16T00:00:002022A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.Authorship 10595275Authorship 10627877Authorship 105991210Authorship 105566715Authorship 105958222Authorship 105449612Authorship 10567861136524349Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, Rakopoulos P, Ramaswamy V, Taccone MS, Mischel PS, Fuller GN, Hawkins C, Stanford W, Taylor MD, Zadeh G, Rutka JTCancer researchCorrection: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Res. 2022 Dec 16; 82(24):4695.Cancer Res2022-12-16T00:00:002022Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma.36250346Khan AB, Lee S, Harmanci AS, Patel R, Latha K, Yang Y, Marisetty A, Lee HK, Heimberger AB, Fuller GN, Deneen B, Rao GInternational journal of cancerCXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. Int J Cancer. 2023 02 15; 152(4):713-724.Int J Cancer2022-10-31T00:00:002022CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.36195959Amit M, Xie T, Gleber-Netto FO, Hunt PJ, Mehta GU, Bell D, Silverman DA, Yaman I, Ye Y, Burks JK, Fuller GN, Gidley PW, Nader ME, Raza SM, DeMonte FJournal of experimental & clinical cancer research : CRDistinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. J Exp Clin Cancer Res. 2022 Oct 04; 41(1):292.J Exp Clin Cancer Res2022-10-04T00:00:002022Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology.36526687Lu L, Marisetty A, Liu B, Kamal MM, Gumin J, Veo B, Cai Y, Kassem DH, Weng C, Maynard ME, Hood KN, Fuller GN, Pan ZZ, Cykowski MD, Dash PK, Majumder SScientific reportsAuthor Correction: REST overexpression in mice causes deficits in spontaneous locomotion. Sci Rep. 2022 Dec 16; 12(1):21759.Sci Rep2022-12-16T00:00:002022Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion.36112052Pokhylevych H, Khose S, Gule-Monroe MK, Chen MM, Fuller G, Gruschkus SK, Sadighi Z, Zaky W, Sandberg DI, McGovern SL, Johnson JMJournal of computer assisted tomographyContrast Enhancement Patterns in Pediatric Glioblastomas. J Comput Assist Tomogr. 2022 Sep 07.J Comput Assist Tomogr2022-09-07T00:00:002022Contrast Enhancement Patterns in Pediatric Glioblastomas.36128585Upadhyay R, Khose S, Pokhylevych H, Paulino AC, McAleer MF, Ghia A, Li J, Yeboa DN, Loghin M, Harrison R, O'Brien B, Kamiya-Matsuoka C, De Groot J, Puduvalli VK, Tatsui C, Alvarez-Breckenridge C, Prabhu S, Rhines L, Zaky W, Lin F, Weinberg JS, Fuller G, Sandberg DI, Johnson JM, McGovern SLNeuro-oncology advancesPatterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac129.Neurooncol Adv2022-08-20T00:00:002022Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis.36598462Pokhylevych H, Khose S, Amer A, Alhasan H, Kaya D, Johnson R, Fuller G, Gruschkus SK, Zaky W, Weinberg JS, Johnson JMJournal of computer assisted tomographyRetrospective Analysis of Imaging Characteristics of Tectal Gliomas. J Comput Assist Tomogr. 2022 Nov 27.J Comput Assist Tomogr2022-11-27T00:00:002022Retrospective Analysis of Imaging Characteristics of Tectal Gliomas.Authorship 1062987536723868Gregory TA, Williford GL, Maronge JM, Alfaro K, Fuller GN, de Groot J, Puduvalli VK, Ballester LY, Majd NKNeuro-oncologyAn expedited strategy for accurate and timely integrated molecular diagnosis of?gliomas. Neuro Oncol. 2023 04 06; 25(4):808-809.Neuro Oncol2023-04-06T00:00:002023An expedited strategy for accurate and timely integrated molecular diagnosis of?gliomas.Authorship 10678657Authorship 10681267Authorship 1067931737051329Ozkizilkaya HI, Johnson JM, O'Brien BJ, McCutcheon IE, Prabhu SS, Ghia AJ, Fuller GN, Huse JT, Ballester LYNeuro-oncology advancesIntracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad026.Neurooncol Adv2023-03-21T00:00:002023Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle.37077830Haider AS, Ene CI, Palmisciano P, Haider M, Rao G, Ballester LY, Fuller GNFrontiers in oncologyConcurrent IDH1 and IDH2 mutations in glioblastoma: A case report. Front Oncol. 2023; 13:1071792.Front Oncol2023-04-03T00:00:002023Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report.37114244Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NKNeuro-oncology advancesCharacterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad032.Neurooncol Adv2023-04-13T00:00:002023Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.Authorship 1075598437487571Rasband JM, Alfattal R, Patel AJ, Fuller GN, Perry A, Lu HCJournal of neuropathology and experimental neurologyCavernous sinus hemangioma: Histopathological spectrum of 8 cases. J Neuropathol Exp Neurol. 2023 09 20; 82(10):884-886.J Neuropathol Exp Neurol2023-09-20T00:00:002023Cavernous sinus hemangioma: Histopathological spectrum of 8 cases.Authorship 1078774237559514Farhat M, Fuller GN, Wintermark M, Chung C, Kumar VA, Chen MThe neuroradiology journalMultifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment. Neuroradiol J. 2023 Aug 10; 19714009231193162.Neuroradiol J2023-08-10T00:00:002023Multifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment.Authorship 10800701337756559Shehabeldin A, Rohra P, Sellen LD, Zhao J, Alqaidy D, Aramin H, Hameed N, Perez YE, Lai Z, Tong YT, Milton DR, Edgerton ME, Fuller G, Hansel D, Prieto VG, Ballester LY, Aung PPArchives of pathology & laboratory medicineUtility of Whole Slide Imaging for Intraoperative Consultation: Experience of a Large Academic Center. Arch Pathol Lab Med. 2023 Sep 26.Arch Pathol Lab Med2023-09-26T00:00:002023Utility of Whole Slide Imaging for Intraoperative Consultation: Experience of a Large Academic Center.37881491Singh SK, Wang Y, Habib A, Priyadarshini M, Kodavali CV, Chen A, Ma W, Wang J, Hameed NUF, Hu B, Fuller GN, Kulich SM, Amankulor N, Colen RR, Edwards LA, Zinn POFrontiers in oncologyTP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro. Front Oncol. 2023; 13:1279806.Front Oncol2023-10-10T00:00:002023TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro.Authorship 108297511Authorship 10833094Authorship 1083214637944358Haider AS, McCutcheon IE, Ene CI, Fuller GN, Schomer DF, Gule-Monroe M, DeMonte F, Ferguson SD, Lang FF, Prabhu SS, Raza SM, Suki D, Weinberg JS, Sawaya RJournal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaSubependymomas of the fourth ventricle: To operate or not to operate? J Clin Neurosci. 2023 Dec; 118:147-152.J Clin Neurosci2023-11-07T00:00:002023Subependymomas of the fourth ventricle: To operate or not to operate?37924213Dagher SA, Lochner RH, Ozkara BB, Schomer DF, Wintermark M, Fuller GN, Ucisik FEThe neuroradiology journalThe T2-FLAIR mismatch sign in oncologic neuroradiology: History, current use, emerging data, and future directions. Neuroradiol J. 2023 Nov 04; 19714009231212375.Neuroradiol J2023-11-04T00:00:002023The T2-FLAIR mismatch sign in oncologic neuroradiology: History, current use, emerging data, and future directions.Authorship 1086523738201434Zheng L, Luthra R, Alvarez HA, San Lucas FA, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen HCancersIntragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors. Cancers (Basel). 2023 Dec 19; 16(1).Cancers (Basel)2023-12-19T00:00:002023Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.Authorship 1089771838414131Kumar VA, Perez A, Young AL, Jones J, O'Brien BJ, Lang FF, Huse JT, Fuller GNNeuropathology : official journal of the Japanese Society of NeuropathologyCollision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytoma. Neuropathology. 2024 Feb 27.Neuropathology2024-02-27T00:00:002024Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytoma.Authorship 10910231338515188Humphries W, Wang Y, Qiao W, Reina-Ortiz C, Abou-Ghazal MK, Crutcher LM, Wei J, Kong LY, Sawaya R, Rao G, Weinberg J, Prabhu SS, Fuller GN, Heimberger ABJournal of translational medicineCorrection: Detecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients. J Transl Med. 2024 Mar 21; 22(1):296.J Transl Med2024-03-21T00:00:002024Correction: Detecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professor24792645Mukherjee M, Byrd T, Brawley VS, Bielamowicz K, Li XN, Merchant F, Maitra S, Sumazin P, Fuller G, Kew Y, Sun D, Powell SZ, Ahmed N, Zhang N, Pati DJournal of neuro-oncologyOverexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme. J Neurooncol. 2014 Aug; 119(1):27-35.J Neurooncol2014-05-04T00:00:002014Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme.24974128Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger ABJournal of the National Cancer InstituteEffect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8).J Natl Cancer Inst2014-06-28T00:00:002014Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.24676140Doucette T, Latha K, Yang Y, Fuller GN, Rao A, Rao GNeuro-oncologySurvivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas. Neuro Oncol. 2014 Sep; 16(9):1220-8.Neuro Oncol2014-03-27T00:00:002014Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.